Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025)
Xtant Medical Holdings (XTNT) reported Asset Writedowns and Impairment of $828000.0 for Q3 2025, up 1527.59% year-over-year from $50872.9 in Q3 2024, and up 1723.53% on a QoQ basis from -$51000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) has 9 years of Asset Writedowns and Impairment data on file, last reported at $828000.0 in Q3 2025.
- Quarterly Asset Writedowns and Impairment rose 1527.59% year-over-year to $828000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.5 million (up 409.69% YoY) and the FY2024 annual result came in at $485000.0, up 35.85% from the prior year.
- Asset Writedowns and Impairment grew to $828000.0 in Q3 2025 per XTNT's latest filing, from -$51000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.4 million in Q3 2022 and bottomed at -$58000.0 in Q3 2024.
- The 5-year median for Asset Writedowns and Impairment is $153000.0 (2023), against an average of $248684.2.
- The widest annual swing landed in 2021, when Asset Writedowns and Impairment jumped 2327.27%; it then plunged 139.53% in 2025.
- Tracing XTNT's Asset Writedowns and Impairment over 5 years: stood at $267000.0 in 2021, then fell by 8.61% to $244000.0 in 2022, then slumped by 116.8% to -$41000.0 in 2023, then soared by 478.05% to $155000.0 in 2024, then surged by 434.19% to $828000.0 in 2025.
- Per Business Quant, the three latest XTNT Asset Writedowns and Impairment figures stand at $828000.0 (Q3 2025), -$51000.0 (Q2 2025), and $541000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 828,000.00 |
| Sep 30, 2025 | 828,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Sep 30, 2024 | -58,000.00 |
| Sep 30, 2024 | -58,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Dec 31, 2022 | 244,000.00 |
| Dec 31, 2022 | 244,000.00 |
| Sep 30, 2022 | 1.43 Mn |
| Sep 30, 2022 | 1.43 Mn |
| Jun 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 49,000.00 |
| Mar 31, 2022 | 318,000.00 |
| Mar 31, 2022 | 318,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 118,000.00 |
| Sep 30, 2021 | 118,000.00 |
| Jun 30, 2021 | 81,000.00 |
| Jun 30, 2021 | 81,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Sep 30, 2020 | 92,000.00 |
| Sep 30, 2020 | 92,000.00 |
| Jun 30, 2020 | 66,000.00 |
| Jun 30, 2020 | 66,000.00 |
| Mar 31, 2020 | 138,000.00 |
| Mar 31, 2020 | 138,000.00 |
| Dec 31, 2019 | 60,000.00 |
| Dec 31, 2019 | 60,000.00 |
| Sep 30, 2019 | 221,000.00 |
| Sep 30, 2019 | 221,000.00 |
| Jun 30, 2019 | 138,000.00 |
| Jun 30, 2019 | 138,000.00 |
| Mar 31, 2019 | 94,000.00 |
| Mar 31, 2019 | 94,000.00 |
| Dec 31, 2015 | 722,647.00 |
| Dec 31, 2015 | 722,647.00 |
| Dec 31, 2014 | 912,549.00 |
| Dec 31, 2014 | 912,549.00 |